FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc., resulting in changes to the drug's labeling. This acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• LIPOFEN (FENOFIBRATE)

Snippet

SUPPL AP for LIPOFEN (FENOFIBRATE)